A tobacco plant that makes five psychedelics: what the lab did and did not do

**Research review** ## The hook "Scientists engineer a tobacco plant with five psychedelics" is the kind of headline people forward without reading. The study is real, but it is about plant biochemistry in a lab, not a product. Here is what was actually done. ## In brief - Berman and colleagues (Science Advances, 2026) reconstructed the full pathway for five natural psychoactive tryptamines in a single plant: psilocin and psilocybin (mushrooms), DMT (plants), and bufotenin and 5-MeO-DMT (the Sonoran Desert toad) [S-001]. - This is laboratory work. People were not studied, and doses and safety were not assessed [S-001]. - The authors also built halogenated analogues that do not occur in nature. Their "therapeutic potential" is the authors' hypothesis, not a result from trials [S-001]. ## What was done Plants, fungi and toads make related molecules by different routes. The team combined enzymes from several kingdoms of life inside one plant. The result describes how the biochemistry works. It is not a recipe [S-001]. ## Why scientists care The authors describe a platform for making psychoactive compounds in plants. In principle this could make research supplies more stable. The path from a lab result to a clinical drug is long, and the paper does not claim otherwise [S-001]. ## Why this is not about cigarettes The headline merges two things: psychoactive molecules and smoking. The study did not examine smoking, smoke composition or the effects of inhaling anything. "Tobacco with psychedelics" describes a plant in a lab, not a finished product [S-001]. ## What is known, what is not, and the risks **Known:** a single plant was made to produce the full pathway for five psychoactive tryptamines, and halogenated analogues were created [S-001]. **Not known:** safety, effects and doses of these substances in people; whether the analogues help treat anything; the scale and cost of such production. **Does not follow from the source:** that such plants are available; that they can be used at home; that smoking or any other use is safe. **Risks:** psychoactive substances can cause serious psychiatric and cardiovascular effects and can interact with medicines. Illegal supply and unknown content are dangerous. If you have a mental health condition or heart disease, or take medication, discuss any question with a doctor first. This article contains no instructions for obtaining or using these substances. ## What next If the topic interests you, follow reports from clinical trials. A lab result does not mean a product is coming. ## Question for readers What matters more to you in work like this: scientific progress, or the risk if the technology spreads beyond labs? Share your view in the comments; we do not give medical advice. ## What was checked—and what the claims mean | Claim | Status | Source | |---|---|---| | Full pathway for five tryptamines in one plant | checked against the abstract (Europe PMC) | S-001 | | Compounds: psilocin, psilocybin, DMT, bufotenin, 5-MeO-DMT | checked against the abstract | S-001 | | Halogenated analogues | checked against the abstract | S-001 | | Therapeutic potential of the analogues | the authors' hypothesis; no trials in people | S-001 | | Safety and effects in people | not measured | S-001 | | Smoking these plants is safe or harmful | not studied; not claimed | — | | The "for science" quote in the original post | not verified; not used | — | | Doses and schedules | not given | — | The full text was not checked; the results section was reviewed only through the abstract. The institute's press release was not retrieved (the saved copy is a Cloudflare challenge page) and is not used. No medical reviewer is assigned and no medical review date is given. **Author:** Serge Luboff. This material is not medical advice and does not replace a doctor's consultation.